ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

RARE Ultragenyx Pharmaceutical Inc

42.75
-0.45 (-1.04%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Ultragenyx Pharmaceutical Inc RARE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.45 -1.04% 42.75 09:00:00
始値 安値 高値 終値 前日終値
44.88 42.675 46.005 42.75 43.20
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0305:00GLOBEUltragenyx Reports First Quarter 2024 Financial Results and..
2024/5/0105:00GLOBEUltragenyx Issues 2023 Corporate Responsibility Report,..
2024/4/3021:00GLOBEUltragenyx Announces Completion of Enrollment in Phase 3..
2024/4/2605:30GLOBEUltragenyx to Host Conference Call for First Quarter 2024..
2024/4/2005:30GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/4/1520:00GLOBEUltragenyx Announces Positive Interim Phase 1/2 Data in..
2024/4/1305:22GLOBEUltragenyx Announces Update to Conference Call Timing to..
2024/4/1221:00GLOBEUltragenyx Announces Upcoming Data Presentations at American..
2024/3/2305:00GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/3/0610:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:30GLOBEUltragenyx to Participate at Investor Conferences in March
2024/2/2406:05GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/2/2207:03EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/1606:04EDGAR2Form 8-K - Current report
2024/2/1606:01GLOBEUltragenyx Reports Fourth Quarter and Full Year 2023..
2024/2/0906:00GLOBEUltragenyx to Host Conference Call for Fourth Quarter and..
2024/2/0622:00GLOBEUltragenyx Announces Data Demonstrating Treatment with UX111..
2024/2/0606:05GLOBEUltragenyx Receives PRIME Designation from European..
2024/1/2606:05GLOBEUltragenyx Announces Completion of Dosing Across Stage 1..
2024/1/2006:00GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2024/1/0821:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
2024/1/0820:03EDGAR2Form 8-K - Current report
2024/1/0801:00GLOBEUltragenyx Reports Preliminary 2023 Revenue; Guidance for..
2024/1/0422:00GLOBEUltragenyx Receives Positive Recommendation from NICE in the..
2024/1/0322:00GLOBEUltragenyx Announces Completion of Enrollment in Global..
2024/1/0306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0306:05GLOBEUltragenyx to Present at the 42nd Annual J.P. Morgan..
2023/12/2207:45DJNUltragenyx to Pay $6 Million to Settle Alleged False..
2023/12/2206:30GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2023/12/2206:02EDGAR2Form 8-K - Current report
2023/12/1822:00GLOBEUltragenyx Receives European Commission Decision for..
2023/11/2106:30GLOBEUltragenyx to Participate at Investor Conferences in..
2023/11/1806:30GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2023/11/0807:00GLOBEUltragenyx to Participate in the Jefferies London Healthcare..
2023/11/0305:17EDGAR2Form 8-K - Current report
2023/11/0305:05GLOBEUltragenyx Reports Third Quarter 2023 Financial Results and..
2023/10/2705:05GLOBEUltragenyx to Host Conference Call for Third Quarter 2023..
2023/10/2405:01GLOBEUltragenyx Announces Closing of Public Offering of Common..
2023/10/2319:31EDGAR2Form 8-K - Current report
2023/10/2105:00GLOBEUltragenyx Reports Inducement Grant Under Nasdaq Listing..
2023/10/2019:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1910:16GLOBEUltragenyx Announces Pricing of Public Offering of Common..
2023/10/1805:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1805:02GLOBEUltragenyx Announces Proposed Public Offering of Common..

最近閲覧した銘柄

Delayed Upgrade Clock